Qingping Jiang

Title: Qingping Jiang: Innovator in Antibody Drug Conjugate Purification

Introduction

Qingping Jiang is a notable inventor based in New Windsor, NY (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the purification of antibody drug conjugates. His innovative work has led to the development of methods that enhance the efficacy and safety of these important therapeutic agents.

Latest Patents

Qingping Jiang holds a patent for the "Purification of antibody drug conjugates using a sodium phosphate gradient." This patent focuses on methods for removing high molecular weight species, specifically aggregates, from antibody drug conjugate preparations. The process involves contacting the preparations of the antibody drug conjugate reaction mixture with a hydroxyapatite resin and selectively eluting the ADC from the resin using a gradient comprising sodium phosphate. This innovation is crucial for improving the quality of antibody drug conjugates.

Career Highlights

Qingping Jiang is currently employed at Pfizer Corporation, a leading global biopharmaceutical company. His work at Pfizer has allowed him to contribute to the advancement of drug development and purification techniques. His expertise in this area has positioned him as a valuable asset to the company and the industry as a whole.

Collaborations

Throughout his career, Qingping has collaborated with several esteemed colleagues, including Durgesh Vasant Nadkarni and Jeffry R Borgmeyer. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Qingping Jiang's contributions to the purification of antibody drug conjugates exemplify the impact of innovative thinking in the biopharmaceutical industry. His patent and work at Pfizer Corporation highlight his commitment to improving therapeutic solutions.